Literature DB >> 17932854

Efficacy of anterior chamber paracentesis after intravitreal triamcinolone injection.

W Chang1, M Chung.   

Abstract

PURPOSE: To investigate the efficacy of anterior chamber paracentesis for intravitreal triamcinolone acetonide injection (IVTA).
METHODS: A prospective, randomized clinical trial was conducted on 30 eyes from 30 patients scheduled for IVTA (4 mg/0.1 mL). Eyes were randomly divided into two groups: eyes that had undergone anterior chamber paracentesis (Group 1, 15 eyes) and eyes that did not have anterior chamber paracentesis (Group 2, 15 eyes). Intraocular pressure (IOP) was measured by Goldmann applanation tonometry at a baseline of 2, 15, 30, and 60 minutes at 1 day and 1 week after the injection. The authors analyzed the short-term postoperative changes of the IOP in each group.
RESULTS: For Group 1, the mean preoperative IOP was 15.33+/-1.72 mmHg, and the postoperative IOP at 2 and 15 minutes were 7.80+/-1.47 and 11.73+/-1.67 mmHg, respectively. For Group 2, there was a significant elevation of IOP (46.73+/-8.26 mmHg) 2 minutes after the injection, which decreased to the normal range (16.13+/-2.61 mmHg) by 15 minutes after the injection. There were no significant differences between the two groups in IOP at 15 minutes postsurgery compared with the distinct difference in IOP at 2 minutes post surgery (Student t-test, p=0.01).
CONCLUSIONS: The findings suggest that routine anterior chamber paracentesis is inappropriate due to the brief immediate postoperative IOP elevation with IVTA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17932854     DOI: 10.1177/112067210701700514

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  4 in total

1.  Effect of dorzolamide-timolol fixed combination prophylaxis on intraocular pressure spikes after intravitreal bevacizumab injection.

Authors:  Sehnaz Ozcaliskan; Faruk Ozturk; Pelin Yilmazbas; Ozlem Beyazyildiz
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

2.  Electroretinographic evaluations of retinal function before, just after, and after intravitreal injections.

Authors:  Kazuma Yagura; Kei Shinoda; Soiti Matsumoto; Gaku Terauchi; Makoto Kawashima; Emiko Watanabe; Harue Matsumoto; Takeshi Iwata; Atsushi Mizota; Yozo Miyake
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

3.  Effect of prophylactic timolol 0.1% gel on intraocular pressure after an intravitreal injection of ranibizumab: a randomized study.

Authors:  Alfredo Pece; Davide Allegrini; Giovanni Montesano; Andrea Fabio Dimastrogiovanni
Journal:  Clin Ophthalmol       Date:  2016-06-17

4.  Acute angle closure attack after an intravitreal bevacizumab injection for branch retinal vein occlusion: a case report.

Authors:  Seongyong Jeong; Min Sagong; Woohyok Chang
Journal:  BMC Ophthalmol       Date:  2017-03-14       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.